In the peripheral blood of patients with advanced melanoma, PD-1 accumulates in the cytoplasm of circulating T lymphocytes, which can supplement the loss of PD-1 on T cell membrane and mediate tumor immune escape by affecting the T cell function (86). This evidence concerns the gene PDCD1 and melanoma.